Organic solvents and the dopaminergic system

International Journal of Occupational Medicine and Environmental Health

Volumn 18, Issue 2, 2005, Pages 103-113

  Gralewicz, Sławomir ^a   Dyzma, Michał ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Dopaminergic system; Drug abuse; Olfaction; Organic solvents; Parkinson's disease; Parkinsonism; Pituitary function; Visual functions

Indexed keywords

ACETONYLACETONE; BENZENE; CARBON DISULFIDE; HEXANE; METHANOL; ORGANIC SOLVENT; STYRENE; TETRACHLOROETHYLENE; TOLUENE; TRICHLOROETHYLENE;

ADULT; AGED; BRAIN REGION; CONFERENCE PAPER; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; FEMALE; GABAERGIC SYSTEM; HEALTH HAZARD; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; MALE; NERVE PROJECTION; NERVOUS SYSTEM; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OCCUPATIONAL EXPOSURE; OLFACTORY BULB; PARKINSON DISEASE; PARKINSONISM; RAT; RETINA; TUBEROHYPOPHYSEAL TRACT;

EID: 22844444081     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (112)

1. Mihic SJ, Harris RA. Molecular mechanisms of anesthetic actions on ligand-gated ion channels. Neurotransmission 1997;13:1-7.
2. 2=-ATPase as targets of organic solvent impact. Life Sci 1995;57:2223-30.
3. Korpela M. Inhibition of synaptosome membrane-bound integral enzymes by organic solvents. Scand J Work Environ Health 1988;15:64-8.
4. Tsuga H, Haga T, Honma T. Effects of toluene exposure on signal transduction: toluene reduced the signalling via stimulation of human muscarinic acetylcholine receptor m2 subtypes in CHO cells. Jpn J Pharmacol 2002;89:282-9.
5. Tsuga H, Honma T. Effects of short-term toluene exposure on ligand binding to muscarinic acetylcholine receptors in the rat frontal cortex and hippocampus. Neurotoxicol Teratol 2002;22:603-6.
6. Balster RL. Neural basis of inhalant abuse. Drug Alcohol Depend 1998;51:207-14.
7. Mutti A, Smargiassi A. Selective vulnerability of dopaminergic systems to industrial chemicals: Risk assessment of related neuroendocrine changes. Toxicol Industr Health 1998; 14:311-23.
8. Woolf NJ. Global and serial neurons form a hierarchically arranged interface proposed to underlie memory and cognition. Neuroscience 1996;74:625-51.
9. Greenfield S, Vaux DJ. Parkinson's disease, Alzheimer's disease and motor neurone disease: identifying a common mechanism. Neuroscience 2002;113:485-92.
10. German DC, Schlusselberg DS, Woodward DJ. Three-dimensional computer reconstruction of midbrain dopaminergic neuronal populations: from mouse to man. J Neural Transm 1983;57:243-54.
11. German DC, Manaye KF. Midbrain dopaminergic neurons (nuclei A8, A9, and A10): Three-dimensional reconstruction in the rat. J Comp Neurol 1993;331:297-309.
12. Oades RD, Halliday GM. Ventral tegmental (A10) system: neurobiology. 1) Anatomy and connectivity. Brain Res Rev 1987;12:117-65.
13. Bunney BS, Chiodo LA, Grace AA. Midbrain dopamine system electrophysiological functioning: a review and new hypothesis. Synapse 1991;9:79-94.
14. Dahlström A, Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brainstem neurons. Acta Physiol Scand 1964;62 Suppl 232:1-55.
15. Deutch AY, Goldstein M, Baldino F, Roth RH. Telencephalic projection of the A8 dopamine cell group. Ann NY Acad Sci 1988;537:27-50.
16. Calabresi P, Mercuri NB, Sancesario G, Bernardi G. Electrophysiology of dopamine-denervated striatal neurons. Brain 1993; 116:433-52.
17. Tanner CM. Occupational and environmental causes of parkinsonism. Occup Med State Art Rev 1992;7:503-13.
18. Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 1966;18:925-64.
19. Fearnley JM, Less AJ. Aging and Parkinson's disease: substantial nigra regional selectivity. Brain 1992;114:2283-301.
20. Liu J, Mori A. Stress, aging, and brain oxidative damage. Neurochem Res 1999;24:1479-97.
21. Delanty N, Dichter MA. Oxidative injury in the nervous system. Acta Neurol Scand 1998;98:145-53.
22. Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Movement Disorders 1998;13:24-34.
23. Warner TT, Schapira AH. Genetic and environmental factors in the cause of Parkinson's disease. Ann Neurol 53 Suppl 2003;3:S16-23.
24. Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, et al. Parkinson disease in twins: an etiologic study. JAMA 1999;281:341-6.
25. Uitti RJ, Snow BL, Shintoh H, Vingerhoets FJ, Hayward M, Hashimoto S, et al. Parkinsonism induced by solvent abuse. Ann Neurol 1994;35:616-9.
26. Finkelstein Y, Vardi J. Progressive parkinsonism in a young experimental physicist following long-term exposure to methanol. Neurotoxicology 2002;23:521-5.
27. Davis LE, Adair JC. Parkinsonism from methanol poisoniong: benefit from treatment with anti-Parkinsonian drugs. Mov Disord 1999;14:520-2.
28. Hageman G, van der Hoek J, van Hout M, van der Laan G, Steur EJ, de Bruin W, et al. Parkinsonism, pyramidal signs, polyneuropathy and cognitive decline after long-term occupational solvent exposure. J Neurol 1999;246:198-206.
29. Kuriwaka R, Mitsui T, Fujiwara S, Nishida Y, Matsumoto T. Loss of postural reflexes in long-term occupational solvent exposure. Eur Neurol 2002;47:85-7.
30. Guehl D, Bezard E, Dovero S, Boraud T, Bioulac B, Gross C. Trichloroethylene and parkinsonism: a human and experimental observation. Eur J Neurol 1999;6:609-11.
31. Cintra A, Andbjer B, Finnman UB, Hagman M, Agnati LF, Hoglund G, et al. Subacute toluene exposure increases DA dysfunction in the 6-OH dopamine lesioned nigrostriatal dopaminergic system of the rat. Neurosci Lett 1996;217:61-5.
32. Weiss B. Risk assessment: the insidious nature of neurotoxicity and the aging brain. Neurotoxicology 1990;11:305-15.
33. Reuhl KR. Delayed expression of neurotoxicity: the problem of silent damage. Neurotoxicology 1990;12:341-6.
34. Smargiassi A, Mutti A, De Rosa A, De Palma G, Negrotti A, Calzetti S. A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy. Neurotoxicology 1998;19:709-12.
35. Pezzoli G, Ricciardi S, Masotto C, Mariani CB, Carenzi A. n-Hexane induces parkinsonism in rodents. Brain Res 1990;531:355-7.
36. Jimenez-Jimenez FJ, Mateo D, Gimenez-Roldan S. Premorbid smoking, alcohol consumption and coffee drinking habits in Parkinson's disease: a case-control study. Mov Disord 1992;7:334-44.
37. Fujii C, Harada S, Ohkoshi N, Hayashi A, Yoshizawa K. Study on Parkinson's disease and alcohol drinking. Nihon Arukoru Yakubutsu Igakkai Zasshi 1998;33:683-91.
38. Oades RD, Halliday GM. Ventral tegmental (A10) system: neurobiology.) I. Anatomy and connectivity. Brain Res Rev 1987;12:117-65.
39. Kalivas PW, Nakamura M. Neural systems for behavioral activation and reward. Curr Opin Neurobiol 1999;9:223-7.
40. Le Moal M, Simon H. Mesocorticolimbic dopaminergic network: Functional and regulatory roles. Phys Rev 1991;71:155-232.
41. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience. Brain Res Rev 1998;28:309-69.
42. Robinson TE, Berridge KC. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 2000;95:91-117.
43. Vanderschuren LJMJ, Kalivas PW. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization. Psychopharmacology 2000;151:99-120.
44. Schutz, CG, Chilcoat HD, Anthony JC. The association between sniffing inhalants and injecting drugs. Compr Psychiatry 1994;35:99-105.
45. Young SJ, Longstaffe S, Tenenbein M. Inhalant abuse and the abuse of other drugs. Am J Drug Alcohol Abuse 1999;25:371-5.
46. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentration in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988;85:5274-8.
47. Bradberry CW. Dose-dependent effect of ethanol on extracellular dopamine in mesolimbic striatum of awake rhesus monkeys: comparison with cocaine across individuals. Psychopharmacology (Berl) 2002;165:67-76.
48. Tizabi Y, Copeland RL Jr, Louis VA, Taylor RE. Effects of combined systemic alcohol and central nicotine administration into ventral tegmental area on dopamine release in the nucleus accumbens. Alcohol Clin Exp Res 2002;26:394-9.
49. Brodie MS, Pesold C, Appel SB. Ethanol directly excites dopaminergic ventral tegmental area reward neurons. Alcohol Clin Exp Res 1999;23:1848-52.
50. Appel SB, Liu Z, McElvain MA, Brodie MS. Ethanol excitation of dopaminergic ventral tegmental area neurons is blocked by quinidine. J Pharmacol Exp Ther 2003;306:437-46.
51. Riegel AC, French ED. An electrophysiological analysis of rat ventral tegmental dopamine neuronal activity during acute toluene exposure. Pharmacol Toxicol 1999;85:37-43.
52. Riegel AC, French ED. Acute toluene induces biphasic changes in rat spontaneous locomotion which are blocked by remoxipride. Pharmacol Biochem Behav 1999;62:399-402.
53. Riegel AC, Ali SF, French ED. Toluene-induced locomotor activity is blocked by 6-hydroxydopamine lesions of the nucleus accumbens and the mGluR2/3 agonist LY379268. Neuropsychopharmacology 2003;28:1440-7.
54. Riegel AC, French ED. Abused inhalants and central reward pathways: electrophysiological and behavioral studies in the rat. Ann NY Acad Sci 2002;965:281-91.
55. Gerasimov MR, Schiffer WK Marstellar D, Ferrieri R, Alexoff D, Dewey SL. Toluene inhalation produces regionally specific changes in extracellular dopamine. Drug Alcohol Depend 2002;65:243-51.
56. Kondo H, Huang J, Ichihara G, Kamijima M, Saito I, Shibata E, et al. Toluene induces behavioral activation without affecting striatal dopamine metabolism in the rat: behavioral and microdialysis studies. Pharmacol Biochem Behav 1995;51:97-101.
57. Diana M, Pistis M, Carboni S, Gesa GL, Rossetti ZL. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proc Natl Acad Sci USA 1993;90:7966-9.
58. Bailey CP, O'Callaghan MJ, Croft AP, Manley SJ, Little HJ. Alterations in mesolimbic dopamine function during the abstinence period following chronic ethanol consumption. Neuropharmacology 2001;41:989-99.
59. Lograno DE, Matteo F, Trabucchi M, Govoni S, Cagiano R, Lacomba C, et al. Effects of chronic ethanol intake at a low dose on the rat brain dopaminergic system. Alcohol 1993;10:45-9.
60. Liljequist S, Engel J. The effect of chronic ethanol administration on central neurotransmitter mechanisms. Med. Biol 1979;57:199-210.
61. Lindholm S, Rosin A, Dahlin I, Georgieva J, Franck J. Ethanol administration potentiated cocaine-induced dopamine levels in the rat nucleus accumbens. Brain Res 2001;915:176-84.
62. Tilson HA, Squibb RE, Meyer OA, Sparber SB. Postnatal exposure to benzene alters the neurobehavioral functioning of rats when tested during adulthood. Neurobehav Toxicol 1980;2:101-6.
63. von Euler G, Ogren SO, Li XM Fuxe K, Gustafsson JA. Persistent effects of subchronic toluene exposure on spatial learning and memory, dopamine mediated locomotor activity and dopamine D2 agonist binding in the rat. Toxicology 1993;77:223-32.
64. von Euler G, Ogren SO, Li XM, Fuxe K, Gustafsson JA. Persistent effects of 80 ppm toluene exposure on dopamine-regulated locomotor activity and prolactin secretion in the male rat. Neurotoxicology 1994;15:621-4.
65. Agrawal AK, Goel SK, Seth PK, Pandya KP. Central nervous system effect of 2,5-hexanediol Neurotoxicology 1985;6:53-9.
66. Pezzoli G, Ricciardi S, Masotto C, Mariani CB, Carenzi A. n-Hexane induces parkinsonism in rodents. Brain Res 1990;531:355-7.
67. Beyer CE, Stafford D, LeSage MG, Glowa JR, Stekete JD. Repeated exposure to inhaled toluene induces behavioral and neurochemical cross-sensitization to cocaine in rats. Psychopharmacology (Berl) 2001;154:198-204.
68. White JF, Carlson GP. Epinephrine-induced cardiac arrhythmias in rabbits exposed to trichloroethylene: role of trichloroethylene metabolites. Toxicol Appl Pharmacol 1981;60:458-65.
69. Szlatenyi CS, Wang RY. Encephalopathy and cranial nerve palsies caused by intentional trichloroethylene inhalation. Am J Emerg Med 1996;14:464-7.
70. Fidler AT, Baker EL, Letz RE. Neurobehavioral effects of occupational exposure to organic solvents among construction painters. Br J Ind Med 1987;44:292-308.
71. Manzo L, Artigas F, Martinez E, Mutti A, Bergamaschi E, Nicotera P, et al. Biochemical markers of neurotoxicity. A review of mechanistic studies and applications. Hum Exp Toxicol 1996;15(Suppl 1): S20-35.
72. Mutti A, Vescovi PP, Falzoi M, Arfini G, Valenti G, Franchira I. Neuroendocrine effects of styrene on occupationally exposed workers. Scand J Work Environ Health 1984;10:225-8.
73. Ferroni C, Selis L, Mutti A, Folli D, Bergamaschi E, Franchini I. Neurobehavioral and neuroendocrine effects of occupational exposure to perchloroethylene. Neurotoxicology 1992;13:243-7.
74. Bergamaschi E, Mutti A, Cavazzini S, Vettori MV, Renzuelli FS, Franchini I. Peripheral markers of neurochemical effects among styrene-exposed workers. Neurotoxicology 1996;17:753-9.
75. Bergamaschi E, Smargiassi A, Mutti A, Cavazzini S, Vettori MV, Alinovi R, et al. Peripheral markers of catecholaminergic dysfunction and symptoms of neurotoxicity among styrene-exposed workers. Int Arch Occup Environ Health 1997;69:209-14.
76. Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000;80:1523-31.
77. Kumar S. Occupational exposure assocciated with reproductive dysfunction. J Occup Health 2004;46:1-19.
78. Plenge-Bonig A, Karmaus W. Exposure to toluene in the printing industry is associated with subfecundity in women but not in men. Occup Environ Med 1999;56:443-8.
79. Sallmen M, Lindholm ML, Anttila A, Kyyronen P, Taskinen H, Nykyri E, et al. Time to pregnancy among wives of men exposed to organic solvents. Occup Environ Med 1998;55:24-30.
80. Sallmen M, Lindholm ML, Kyyronen P, Nykyri E, Anttila A, Taskinen H, et al. Reduced fertility among women exposed to organic solvents. Am J Ind Med 1995;27:699-713.
81. Smith EM, Hammonds-Ehlers M, Clark MK, Kirchner HL, Fuortes L. Occupational exposures and risk of female infertility. Occup Environ Med 1997;39:138-47.
82. Romanelli A, Falzoi M, Mutti A, Bergamaschi E, Franchini I. Effects of some monocyclic aromatic solvents and their metabolites on brain dopamine in rabbits. J Appl Toxicol 1986;6:431-35.
83. Andersson K, Nilsen OG, Toftgard R, Eneroth P, Gustafsson JA. Increased amine turnover in several hypothalamic noradrenaline terminal systems and changes in GH, LH and prolactin secretion in the male rat by low concentration of toluene. Neurotoxicology 1983;4:43-51
84. von Euler G, Fuxe K, Hansson T, Ogren S-O, Agnati LF, Eneroth P, et al. Effects of chronic toluene exposure on central monoamine and peptide receptors and their interaction in the adult male rat. Toxicology 1988;52:103-26.
85. Hsieh GC, Sharma RP, Parker RD, Coulombe RA Jr. Evaluation of toluene exposure via drinking water on levels of regional brain biogenic monoamines and their metabolites in CD-1 mice. Ecotoxicol Environ Saf 1990;20:175-84.
86. Hsieh GC, Sharma RP, Parker RD. Subclinical effects of groundwater contaminants. IV. Effects of repeated oral exposure to combination of benzene and toluene on regional brain monoamine. Arch Toxicol 1990;64:669-76.
87. Jarry H, Metten M, Gamer AO, Wuttke W. Effect of 5-day styrene inhalation on serum prolactin levels and on hypothalamic and striatal catecholamine concentrations in male rats. Arch Toxicol 2002;76:657-63.
88. Trombley PQ, Shepherd GM. Synaptic transmission and modulation in the olfactory bulb. Curr Opin Neurobiol 1993;3:540-7.
89. Hsia AY, Vincent JD, Lledo PM. Dopamine depresses synaptic input into the olfactory bulb. J Neurophysiol 1999;82:1082-5.
90. Coronas V, Krantic S, Jourdan F, Moyse E. Dopamine receptor coupling to adenyl cyclase in rat olfactory pathway: a combined pharmacological-radiographic approach. Neuroscience 1999;90:69-78.
91. Berendse HV, Booij J, Francot CM, Bergmans PL, Hijman R, Stoof JC, et al. Subclinical dopaminergic dysfunction in asymptotic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol 2001;50:34-41.
92. Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, et al. Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord 2001;16:41-6.
93. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 2002;249 Suppl 3:1-5.
94. Ghantous H, Dencker L, Gabrielsson J, Danielsson BR, Bergman K. Accumulation and turnover of metabolites of toluene and xylene in nasal mucosa and olfactory bulb in the mouse. Pharmacol Toxicol 1990;66:87-92.
95. Schwartz BS, Ford DP, Bolla KI, Agnew J, Rothman N, Bleecker ML. Solvent-associated decrements in olfactory function in paint manufacturing workers. Am J Ind Med 1990;18:697-706.
96. Ryan CM, Morrow LA, Hodgson M. Cacosmia and neurobehavioral dysfunction associated with occupational exposure to mixtures of organic solvents. Am J Psychiat 1988;145:1442-5.
97. Sandmark B, Broms I, Lofgreen L, Ohlson CG. Olfactory function in painters exposed to organic solvents. Scand J Work Environ Health 1989;15:60-3.
98. Dalton P, Cowart B, Dilks D, Gould M, Less PS, Stefaniak A, et al. Olfactory function in workers exposed to styrene in the reinforced-plastics industry. Am J Ind Med 2003;44:1-11.
99. Djamgoz MBA, Wagner HJ. Localization and function of dopamine in the adult vertebrate retina. Neurochem Int 1992;20:139-91.
100. Mergler D, Blain L, Lagace JP. Solvent related colour vision loss: an indicator of neural damage? Int Arch Occup Environ Health 1987;59:313-21.
101. Zavalić M, Mandić Z, Turk R, Bogadi-Sare A, Plavec D, Skender LJ. Qualitative color vision impairment in toluene-exposed workers. Int Arch Occup Environ Health 1998;71:194-200.
102. Semple S, Dick F, Osborne A, Cherrie JW, Soutar A, Seaton A, et al. N. Impairment of colour vision in workers exposed to organic solvents. Occup Environ Med 2000;57:582-7.
103. Gong Y, Kishi R, Kasai S, Katakura Y, Fujiwara K, Umemura T, et al. Visual dysfunction in workers exposed to a mixture of organic solvents. Neurotoxicology 2003;24:703-10.
104. Dick F, Semple S, Soutar A, Osborne A, Cherrie JW, Seaton A. Is colour vision impairment associated with cognitive impairment in solvent exposed workers? Occup Environ Med 2004;61:76-8.
105. Gobba F, Cavalleri A. Color vision impairment in workers exposed to neurotoxic chemicals. Neurotoxicoology 2003;24:693-702.
106. Vettori MV, Corradi D, Coccini T, Carta A, Cavazzini S, Manzo L, et al. A. Styrene-induced changes in amacrine retinal cells: An experimental study in the rat. Neurotoxicology 2000;21:607-14.
107. Grace AA. The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 2000;95(2):119-28.
108. Pani L, Porcella A, Gessa GL. The role of stress in the patophysiology of the dopaminergic system. Mol Psychiat 2000;5:14-21.
109. Morrow BA, Redmond AJ, Roth RH, Elsworth JD. The predator odor, TMT, displays a unique, stress-like pattern of dopaminergic and endocrinological activation in the rat. Brain Res 2000;864:146-51.
110. Vanderwolf CH, Zibrowski EM, Wakarchuk D. The ability of various chemicals to elicit olfactory beta-waves in the pyriform cortex of meadow voles (Microtus pennsylvanicus) and laboratory rats (Rattus norvegicus). Brain Res 2002;924(2):151-8.
111. Zibrowski EM, Hoh TE, Vanderwolf CH. Fast wave activity in the rat rhinencephalon: elicitation by the odors of phytochemicals, organic solvents, and a rodent predator. Brain Res 1998;800:207-15.
112. Hillefors-Berglund M, Liu Y, von Euler G. Persistent, specific and dose-dependent effects of toluene exposure on dopamine D2 agonist binding in the rat caudate-putamen. Toxicology 1995;100:185-94.